
Shelter Pharma Ltd Schedules Investor Conference Call to Discuss H2 and FY2026 Financial Results
Shelter Pharma Limited is set to host an investor conference call on Wednesday, June 10, 2026. The event is scheduled for 3:30 PM IST and aims to discuss the company's Audited Financial Results for both the half year (H2) and the full fiscal year ended March 31, 2026, alongside providing comprehensive business and operational updates.The management team will be represented at the conference call by MUSTAQIM NISARAHMED SABUGAR, Managing Director. The necessary details for participation in the investor meeting are provided below:
| Meeting Platform | Details |
|---|---|
| Date & Time | Wednesday, June 10, 2026 at 3:30 PM IST |
| Meeting Platform | Zoho Meeting |
| Meeting Link | https://meet.zoho.in/pqjh-ito-tup |
| Meeting ID | 1354132174 |
| Passcode | tjuann |
Company Profile and Focus
Shelter Pharma Ltd, established in 1965, has maintained a strong presence in the natural healthcare sector. The company specializes in developing safe and effective herbal solutions by combining the principles of Ayurveda with modern research and technology.With a commitment to innovation, quality, and affordability, Shelter Pharma helps promote holistic wellness through its products. The company continues to expand its global reach while remaining dedicated to its mission: 'Curing Naturally, Empowering Health.'
Stock Price Movement
At 11:52, the stock for Shelter Pharma Ltd is trending lower, currently trading at ₹30.10, which represents a 4.44% dip. The shares have traded within an intraday range spanning from a low of ₹30.00 to a high of ₹30.77.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.